denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Symposia: ASH-a-Palooza
Program: Trainee Activities and Services
Hematology Disease Topics & Pathways:
Research, clinical trials, Clinical Research, Workforce, health outcomes research, Diseases, Lymphoid Malignancies, Myeloid Malignancies, survivorship
Hematology Disease Topics & Pathways:
Research, clinical trials, Clinical Research, Workforce, health outcomes research, Diseases, Lymphoid Malignancies, Myeloid Malignancies, survivorship
Friday, December 8, 2023: 1:30 PM-2:00 PM
Sections 122 and 124 A
(Petco Park)
Friday, December 8, 2023: 2:40 PM-3:10 PM
Sections 122 and 124 A
(Petco Park)
Speakers:
Rajshekhar Chakraborty, MD, Columbia University Irving Medical Center
,
Julie E Chang, MD, University of Wisconsin
,
Alison W Loren, MD, ARRAY(0xfc1a688)
,
Matthew L. Ulrickson, MD, Banner MD Anderson Cancer Center
,
Alison R. Walker, MD, MPH, MBA, H.Lee Moffitt Cancer Center & Research Institute
and
Amy Y Wang, MD, MPH, Northshore University HealthSystem
Disclosures:
Chakraborty: AbbVie: Research Funding; Genentech: Research Funding; Adaptive Biotech: Consultancy, Honoraria; Sanofi: Consultancy, Honoraria; Janssen: Consultancy, Honoraria. Chang: Genetech: Research Funding; Adaptive Biotechnologies: Research Funding; MorphoSys AG: Consultancy; BeiGene: Membership on an entity's Board of Directors or advisory committees; AbbVie: Membership on an entity's Board of Directors or advisory committees; Epizyme: Membership on an entity's Board of Directors or advisory committees; Genentech: Membership on an entity's Board of Directors or advisory committees. Ulrickson: Gilead Sciences: Consultancy, Ended employment in the past 24 months; Stemline: Consultancy, Ended employment in the past 24 months; AbbVie: Consultancy, Ended employment in the past 24 months.